These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11226445)

  • 1. Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol.
    Xu J; Chen H; Ma T; Wu X
    Int J Gynaecol Obstet; 2001 Mar; 72(3):245-51. PubMed ID: 11226445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus.
    Herabutya Y; Chanarachakul B; Punyavachira P
    Int J Gynaecol Obstet; 2003 Dec; 83(3):293-7. PubMed ID: 14643040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
    Ferguson I; Scott H
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
    Zou LY; Fan L
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
    Nisand I; Bettahar K;
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone.
    Norman JE; Thong KJ; Baird DT
    Lancet; 1991 Nov; 338(8777):1233-6. PubMed ID: 1682644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
    Frank K; Gerychová R; Janků P; Huser M; Ventruba P
    Ceska Gynekol; 2015 Dec; 80(6):451-5. PubMed ID: 26741161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol for termination of second trimester pregnancy in a scarred uterus.
    Shammas AG; Momani MD
    Saudi Med J; 2006 Aug; 27(8):1173-6. PubMed ID: 16883447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.
    Fiala C; Safar P; Bygdeman M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):190-5. PubMed ID: 12860340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
    Ebbers S; Creemers JW; Lotgering FK
    Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
    Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India.
    Coyaji K; Elul B; Krishna U; Otiv S; Ambardekar S; Bopardikar A; Raote V; Ellertson C; Winikoff B
    Contraception; 2002 Jul; 66(1):33-40. PubMed ID: 12169379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second trimester therapeutic abortion using mifepristone and oral misoprostol in a woman with two previous caesarean sections and a cone biopsy.
    Oteri O; Hopkins R
    J Matern Fetal Med; 1999; 8(6):300-1. PubMed ID: 10582866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.